NHS London Branded Medicines - Tranche B - September 2023
Details
- Buyer
- NHS England
- Supplier(s)
35 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- Accord UK Ltd
- Almirall
- Astra Zeneca UK Limited
- Bayer Public Limited Company
- Celltrion Healthcare United Kingdom Ltd
- CST Pharma Limited
- Eli Lilly and Company Ltd
- Galapagos Biotech UK Ltd
- GEDEON RICHTER (UK) LIMITED
- Gilead Sciences Ltd, 280 High Holborn
- GLAXOSMITHKLINE UK LIMITED
- Ipsen
- Janssen Cilag Ltd
- Kent Pharma Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Mylan
- Neon Healthcare Ltd
- Novartis Pharmaceutical UK Ltd
- Novo Nordisk Ltd
- Organon Pharmaceuticals UK Ltd
- Orifarm UK
- Pfizer Liimted
- Ranbaxy (UK) Ltd
- Roche Products Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- Teva UK Ltd
- Thornton and Ross
- Typharm Ltd
- UCB Pharma Ltd
- Zentiva Pharma UK Ltd
- Value
- GBP 46
- Topic
- Pharmaceutical products
- Published
- 8 August 2023
- Source
- uk:find_a_tender
Tender description
Project Title: NHS London Branded Medicines - Tranche B - September 2023<br/><br/>Offer reference number: CM/PHR/22/5677<br/><br/>CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Lot 1: CM/PHR/22/5677/01 - NHS London Branded Medicines - Tranche B Lot 1 CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Lot 2: CM/PHR/22/5677/02 - NHS London Branded Medicines - Tranche B Lot 2 CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Timeline
- Completed: Award date14 July 2023
- Completed: Award published8 August 2023Current notice
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS London Branded Medicines - Tranche B - September 2023.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 357£15.0bn
- 293£2.8bn
- 263£19.7bn
- 253£892.5m
- 246£509.3m
- 203£1.0bn
- 140£895.5m
- 115£59.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
